Financial Performance - Revenue for Q3 2023 reached ¥670,524,337.93, an increase of 18.27% compared to the same period last year[5] - Net profit attributable to shareholders for Q3 2023 was ¥35,031,643.73, representing a significant increase of 67.01% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥36,412,622.53, up 133.19% from the previous year[5] - Basic and diluted earnings per share for Q3 2023 were both ¥0.27, an increase of 35.00% year-on-year[5] - The net profit for Q3 2023 was CNY 79,509,818.72, compared to CNY 68,121,869.33 in Q3 2022, reflecting an increase of about 16.5%[24] - The basic and diluted earnings per share for Q3 2023 were both CNY 0.70, up from CNY 0.65 in the same period last year, indicating a growth of 7.7%[24] - The total profit for Q3 2023 was CNY 91,677,959.55, compared to CNY 89,617,649.88 in Q3 2022, reflecting a growth of approximately 2.4%[23] Assets and Equity - Total assets as of September 30, 2023, amounted to ¥1,690,389,932.99, a 142.00% increase compared to the end of the previous year[9] - Shareholders' equity attributable to the parent company reached ¥1,408,877,629.95, reflecting a 179.56% increase year-on-year due to the completion of the IPO[9] - The company’s total equity as of September 30, 2023, was CNY 1,409,105,446.52, up from CNY 504,173,841.94 at the beginning of the year, reflecting an increase of about 178.63%[20] Cash Flow - The net cash flow from operating activities for the first nine months of 2023 was ¥17,281,463.78, down 88.41% compared to the same period last year[9] - The net cash flow from operating activities for Q3 2023 was CNY 17,281,463.78, a significant decrease from CNY 149,130,243.57 in Q3 2022[26] - The cash and cash equivalents at the end of Q3 2023 totaled CNY 429,927,977.55, compared to CNY 126,754,642.82 at the end of Q3 2022, showing an increase of approximately 238.5%[27] - The net cash flow from investing activities for Q3 2023 was CNY -522,078,268.69, compared to CNY -21,467,862.66 in Q3 2022, indicating a larger outflow[26] - The net cash flow from financing activities for Q3 2023 was CNY 817,899,952.31, a significant improvement from CNY -159,794,828.29 in Q3 2022[27] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 19,528[10] - The largest shareholder, Jiangsu Changshun Group, holds a 44.42% stake in the company[10] - The total number of restricted shares at the beginning of the period was 105,128,204, with no shares released during the period, and an increase of 1,806,530 shares, resulting in a total of 106,934,734 restricted shares at the end of the period[12] - Jiangsu Changshun Group holds 62,266,851 shares, accounting for 44.42% of the total shares, with no changes in restricted shares during the period[12] - The top ten shareholders include CITIC Securities with 602,658 shares and Everbright Securities with 566,634 shares, all holding common shares[11] - The company has no changes in the number of restricted shares for major shareholders, with all remaining unchanged until their respective release dates[12] - The company’s actual controller, Jiangsu Changshun Group, has a significant influence on the shareholding structure, holding 44.42% of the total shares[11] - The total number of shares held by the top ten unrestricted shareholders is 3,746,000, indicating a concentrated ownership structure[11] Strategic Initiatives - The company plans to invest CNY 600,000,000 in the "Carbon Dioxide Polyether and High-Performance Polyol Project" to support the green transformation of the chemical industry[14] - The company has established a wholly-owned subsidiary in Lianyungang, Jiangsu Province, to facilitate the implementation of its new investment project[14] - The polymer polyol project has entered the trial production phase as of September 15, 2023, with product indicators reaching industry-leading levels[15] - The company aims to expand its market share in high-end and overseas markets to improve sustainable profitability[15] - The company continues to focus on maintaining its market position and shareholder value through strategic management of its equity structure[12] - The company’s future outlook remains stable with no significant changes in shareholder dynamics anticipated in the near term[12] Operating Costs - The total operating costs for Q3 2023 were CNY 1,727,910,819.44, an increase from CNY 1,672,651,890.38 in Q3 2022, representing a growth of approximately 3.3%[23] - Research and development expenses for Q3 2023 were CNY 8,156,905.11, up from CNY 4,406,492.62 in Q3 2022, marking an increase of about 85.5%[23]
长华化学(301518) - 2023 Q3 - 季度财报